Literature DB >> 32645136

Clinical efficacy of anakinra to mitigate CAR T-cell therapy-associated toxicity in large B-cell lymphoma.

Paolo Strati1, Sairah Ahmed1,2, Partow Kebriaei2, Loretta J Nastoupil1, Catherine M Claussen1, Grace Watson1, Sandra B Horowitz3, Anne Rain T Brown3, Bryan Do3, Maria A Rodriguez1, Ranjit Nair1, Elizabeth J Shpall2, Michael R Green1,4, Sattva S Neelapu1, Jason R Westin1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32645136      PMCID： PMC7362369          DOI： 10.1182/bloodadvances.2020002328

Source DB:  PubMed          Journal:  Blood Adv        ISSN： 2473-9529


× No keyword cloud information.
  10 in total

1.  Self-Reported Incident Hypertension and Long-Term Kidney Function in Living Kidney Donors Compared with Healthy Nondonors.

Authors:  Courtenay M Holscher; Christine E Haugen; Kyle R Jackson; Jacqueline M Garonzik Wang; Madeleine M Waldram; Sunjae Bae; Jayme E Locke; Rhiannon D Reed; Krista L Lentine; Gaurav Gupta; Matthew R Weir; John J Friedewald; Jennifer Verbesey; Matthew Cooper; Dorry L Segev; Allan B Massie
Journal:  Clin J Am Soc Nephrol       Date:  2019-09-19       Impact factor: 8.237

Review 2.  Chimeric antigen receptor T-cell therapy - assessment and management of toxicities.

Authors:  Sattva S Neelapu; Sudhakar Tummala; Partow Kebriaei; William Wierda; Cristina Gutierrez; Frederick L Locke; Krishna V Komanduri; Yi Lin; Nitin Jain; Naval Daver; Jason Westin; Alison M Gulbis; Monica E Loghin; John F de Groot; Sherry Adkins; Suzanne E Davis; Katayoun Rezvani; Patrick Hwu; Elizabeth J Shpall
Journal:  Nat Rev Clin Oncol       Date:  2017-09-19       Impact factor: 66.675

3.  Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells.

Authors:  Margherita Norelli; Barbara Camisa; Giulia Barbiera; Laura Falcone; Ayurzana Purevdorj; Marco Genua; Francesca Sanvito; Maurilio Ponzoni; Claudio Doglioni; Patrizia Cristofori; Catia Traversari; Claudio Bordignon; Fabio Ciceri; Renato Ostuni; Chiara Bonini; Monica Casucci; Attilio Bondanza
Journal:  Nat Med       Date:  2018-05-28       Impact factor: 53.440

4.  CAR T cell-induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade.

Authors:  Theodoros Giavridis; Sjoukje J C van der Stegen; Justin Eyquem; Mohamad Hamieh; Alessandra Piersigilli; Michel Sadelain
Journal:  Nat Med       Date:  2018-05-28       Impact factor: 53.440

5.  Therapeutic role of anakinra, an interleukin-1 receptor antagonist, in the management of secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction/macrophage activating syndrome in critically ill children*.

Authors:  Surender Rajasekaran; Katherine Kruse; Karen Kovey; Alan T Davis; Nabil E Hassan; Akunne N Ndika; Sandra Zuiderveen; James Birmingham
Journal:  Pediatr Crit Care Med       Date:  2014-06       Impact factor: 3.624

6.  CD4/CD8 T-Cell Selection Affects Chimeric Antigen Receptor (CAR) T-Cell Potency and Toxicity: Updated Results From a Phase I Anti-CD22 CAR T-Cell Trial.

Authors:  Nirali N Shah; Steven L Highfill; Haneen Shalabi; Bonnie Yates; Jianjian Jin; Pamela L Wolters; Amanda Ombrello; Seth M Steinberg; Staci Martin; Cindy Delbrook; Leah Hoffman; Lauren Little; Anusha Ponduri; Haiying Qin; Haris Qureshi; Alina Dulau-Florea; Dalia Salem; Hao-Wei Wang; Constance Yuan; Maryalice Stetler-Stevenson; Sandhya Panch; Minh Tran; Crystal L Mackall; David F Stroncek; Terry J Fry
Journal:  J Clin Oncol       Date:  2020-04-14       Impact factor: 44.544

7.  Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexate.

Authors:  Mark C Genovese; Stanley Cohen; Larry Moreland; Deborah Lium; Sean Robbins; Richard Newmark; Pirow Bekker
Journal:  Arthritis Rheum       Date:  2004-05

8.  Hitting a Moving Target: Successful Management of Diffuse Large B-cell Lymphoma Involving the Mesentery With Volumetric Image-guided Intensity Modulated Radiation Therapy.

Authors:  Alison K Yoder; Jillian R Gunther; Sarah A Milgrom; Dragan Mirkovic; Loretta Nastoupil; Sattva Neelapu; Michelle Fanale; Nathan Fowler; Jason Westin; Hun Ju Lee; M Alma Rodriguez; Swaminathan P Iyer; Luis Fayad; Yago L Nieto; Chitra Hosing; Sairah Ahmed; L Jeffrey Medeiros; Joseph D Khoury; Naveen Garg; Behrang Amini; Bouthaina S Dabaja; Chelsea C Pinnix
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2018-09-10

9.  Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome: Reanalysis of a Prior Phase III Trial.

Authors:  Bita Shakoory; Joseph A Carcillo; W Winn Chatham; Richard L Amdur; Huaqing Zhao; Charles A Dinarello; Randall Q Cron; Steven M Opal
Journal:  Crit Care Med       Date:  2016-02       Impact factor: 7.598

10.  Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition.

Authors:  Raphaela Goldbach-Mansky; Natalie J Dailey; Scott W Canna; Ana Gelabert; Janet Jones; Benjamin I Rubin; H Jeffrey Kim; Carmen Brewer; Christopher Zalewski; Edythe Wiggs; Suvimol Hill; Maria L Turner; Barbara I Karp; Ivona Aksentijevich; Frank Pucino; Scott R Penzak; Margje H Haverkamp; Leonard Stein; Barbara S Adams; Terry L Moore; Robert C Fuhlbrigge; Bracha Shaham; James N Jarvis; Kathleen O'Neil; Richard K Vehe; Laurie O Beitz; Gregory Gardner; William P Hannan; Robert W Warren; William Horn; Joe L Cole; Scott M Paul; Philip N Hawkins; Tuyet Hang Pham; Christopher Snyder; Robert A Wesley; Steven C Hoffmann; Steven M Holland; John A Butman; Daniel L Kastner
Journal:  N Engl J Med       Date:  2006-08-10       Impact factor: 91.245
  10 in total
  41 in total

1.  Clinical and radiologic correlates of neurotoxicity after axicabtagene ciloleucel in large B-cell lymphoma.

Authors:  Paolo Strati; Loretta J Nastoupil; Jason Westin; Luis E Fayad; Sairah Ahmed; Nathan H Fowler; Fredrick B Hagemeister; Hun J Lee; Swaminathan P Iyer; Ranjit Nair; Simrit Parmar; Maria A Rodriguez; Felipe Samaniego; Raphael E Steiner; Michael Wang; Chelsea C Pinnix; Sherry Adkins; Catherine M Claussen; Charles S Martinez; Misha C Hawkins; Nicole A Johnson; Prachee Singh; Haleigh E Mistry; Sandra Horowitz; Shirley George; Lei Feng; Partow Kebriaei; Elizabeth J Shpall; Sattva S Neelapu; Sudhakar Tummala; T Linda Chi
Journal:  Blood Adv       Date:  2020-08-25

Review 2.  Managing therapy-associated neurotoxicity in children with ALL.

Authors:  Deepa Bhojwani; Ravi Bansal; Alan S Wayne
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

Review 3.  Taming the beast: CRS and ICANS after CAR T-cell therapy for ALL.

Authors:  Vipul S Sheth; Jordan Gauthier
Journal:  Bone Marrow Transplant       Date:  2020-11-24       Impact factor: 5.483

Review 4.  Management of hemophagocytic lymphohistiocytosis (HLH) associated with chimeric antigen receptor T-cell (CAR-T) therapy using anti-cytokine therapy: an illustrative case and review of the literature.

Authors:  Ajay Major; Jennifer Collins; Caroline Craney; Alisa K Heitman; Emily Bauer; Elizabeth Zerante; Wendy Stock; Michael R Bishop; Jagoda Jasielec
Journal:  Leuk Lymphoma       Date:  2021-02-09

Review 5.  Beyond the storm - subacute toxicities and late effects in children receiving CAR T cells.

Authors:  Haneen Shalabi; Juliane Gust; Agne Taraseviciute; Pamela L Wolters; Allison B Leahy; Carlos Sandi; Theodore W Laetsch; Lori Wiener; Rebecca A Gardner; Veronique Nussenblatt; Joshua A Hill; Kevin J Curran; Timothy S Olson; Colleen Annesley; Hao-Wei Wang; Javed Khan; Marcelo C Pasquini; Christine N Duncan; Stephan A Grupp; Michael A Pulsipher; Nirali N Shah
Journal:  Nat Rev Clin Oncol       Date:  2021-01-25       Impact factor: 66.675

Review 6.  Bispecific Antibodies: A Review of Development, Clinical Efficacy and Toxicity in B-Cell Lymphomas.

Authors:  Ross Salvaris; Jeremy Ong; Gareth P Gregory
Journal:  J Pers Med       Date:  2021-04-29

7.  Critically Ill Patients Treated for Chimeric Antigen Receptor-Related Toxicity: A Multicenter Study.

Authors:  Cristina Gutierrez; Anne Rain T Brown; Heather P May; Amer Beitinjaneh; R Scott Stephens; Prabalini Rajendram; Joseph L Nates; Stephen M Pastores; Ananda Dharshan; Alice Gallo de Moraes; Matthew K Hensley; Lei Feng; Jennifer N Brudno; Janhavi Athale; Monalisa Ghosh; James N Kochenderfer; Alejandro S Arias; Yi Lin; Colleen McEvoy; Elena Mead; Jason Westin; Natalie Kostelecky; Agrima Mian; Megan M Herr
Journal:  Crit Care Med       Date:  2022-01-01       Impact factor: 7.598

8.  Hemophagocytic lymphohistiocytosis-like toxicity (carHLH) after CD19-specific CAR T-cell therapy.

Authors:  Melissa R Hines; Camille Keenan; Gabriela Maron Alfaro; Cheng Cheng; Yinmei Zhou; Akshay Sharma; Caitlin Hurley; Kim E Nichols; Stephen Gottschalk; Brandon M Triplett; Aimee C Talleur
Journal:  Br J Haematol       Date:  2021-07-15       Impact factor: 6.998

Review 9.  CAR T-Cells for CNS Lymphoma: Driving into New Terrain?

Authors:  Philipp Karschnia; Jens Blobner; Nico Teske; Florian Schöberl; Esther Fitzinger; Martin Dreyling; Joerg-Christian Tonn; Niklas Thon; Marion Subklewe; Louisa von Baumgarten
Journal:  Cancers (Basel)       Date:  2021-05-20       Impact factor: 6.639

Review 10.  CAR-T Cell Therapy: Mechanism, Management, and Mitigation of Inflammatory Toxicities.

Authors:  Joseph W Fischer; Nirjal Bhattarai
Journal:  Front Immunol       Date:  2021-06-18       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.